PFIZER ASIA MANUFATURING PTE LTD

PFIZER ASIA MANUFACTURING PTE LTD Company Introduction

PFIZER ASIA MANUFACTURING PTE LTD is a manufacturing company (factory).

Pfizer Asia Manufacturing Pte Ltd is a key pharmaceutical manufacturing facility located in Singapore, operating as a subsidiary of the global pharmaceutical giant, Pfizer Inc. This entity is dedicated to the production of a wide range of pharmaceutical products, including medicines and vaccines, for distribution across Asia and potentially other global markets. As a manufacturing plant, it plays a critical role in Pfizer's supply chain, ensuring the consistent and high-quality production of essential healthcare solutions. The facility adheres to stringent international manufacturing standards (e.g., Good Manufacturing Practices - GMP) and utilizes advanced technology and processes to develop and produce innovative medicines. Its operations contribute significantly to the local economy through employment and investment in research and development, solidifying Singapore's position as a hub for advanced manufacturing in the life sciences sector.

Pfizer Asia Manufacturing Pte Ltd in Singapore primarily focuses on the production of a wide range of pharmaceutical products. While specific, exhaustive lists of products manufactured at this precise facility are proprietary and not publicly disclosed, the plant is known to contribute to Pfizer's global supply chain for many of its key medicines. These generally include prescription medicines across various therapeutic areas such as oncology, immunology, cardiovascular diseases, infectious diseases, and rare diseases. The facility is also involved in the manufacturing of vaccines, including components or final forms of some of Pfizer's major vaccine products like the Prevnar family of pneumococcal vaccines and has been implicated in the production efforts for the Comirnaty COVID-19 vaccine. Furthermore, it produces sterile injectable medicines and complex biologics, which are often advanced protein-based therapies. Examples of therapeutic areas covered by Pfizer's broader product portfolio, which would likely be supported by such a manufacturing site, include treatments for inflammatory conditions, neurological disorders, and metabolic diseases.